A CANCER treatment drug is still not available to sufferers in Fife, despite being approved by the Scottish Medicines Consortium in August.
Abiraterone, which treats prostate cancer, can extend the lives of men with incurable conditions and was previously only available in England and Wales.
Methil-based MSP Claire Baker has previously written to NHS Fife for an update on the availability of the drug, with her reply stating that, as part of the South East Scotland Cancer Network (SCAN), it will be bound by an ultimate decision taken by NHS Lothian on behalf of the Cancer Network. However, NHS Lothian has yet to sign off the treatment.
Ms Baker said: “The drug was approved in August, yet sufferers in Fife cannot get access to the treatment until it is signed off by NHS Lothian. This decision has still not been taken and I will now be writing to NHS Lothian to call on it now to take the decision.”